medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2022, Number 3

<< Back Next >>

An Med Asoc Med Hosp ABC 2022; 67 (3)

Ventricular circulatory assistance. Experience of the HSMU Cardiology

Calderón AMC, Hernández PAL, Jiménez ERD, Lozano TVM

Language: Spanish
References: 12
Page: 184-189
PDF size: 268.69 Kb.


ABSTRACT

Introduction: the ventricular assist device has proven to be the only effective therapeutic resource for the management of severe ventricular and/or biventricular failure that does not respond to maximum pharmacological treatment and aortic counterpulsation. Objective: to report the experience of the placement of ventricular assist devices in patients with heart failure refractory to usual treatment of the High Specialty Medical Unit (HSMU) of the Hospital de Cardiología del Centro Médico Nacional Siglo XXI. Material and methods: in accordance with the program established by the HSMU cardiology for ventricular assist device placement, a retrospective case series of 52 adult patients, of any age, who required a ventricular assist device was carried out; the type of device, indications, complications and time of use of the ventricular assist device were evaluated. Results: 4 types of device were placed: Levitronix (15%), ECMO (75%), Vitacor (4%) and HeartMate II (6%). 100% were in class 1 of the INTERMACS classification; 78% were bridge to recovery, 14% bridge to transplant and 6% definitive therapy. Survival was 48% and complications were: renal failure, infections, ventricular assist device dysfunction, and bleeding. Conclusions: ventricular assist devices are a first-world tool with satisfactory short- and long-term results.


REFERENCES

  1. Calderón M, Verdín R. Manual de asistencia circulatoria y trasplante cardiopulmonar. Capítulo 2, 7, 10,-15:3-110. Edición Nueva, Editorial Interamericana McGraw-Hill, Editorial Interamericana, México, D.F. 1995 ISBN 968-25-2220-X.

  2. Braunwald E. Tratamiento de la insuficiencia cardiaca: asistencia circulatoria "Cardiología", Vol. 1, Capítulo 7, Editorial Marbán, 2004. 737-756 ISBN.

  3. Suarez-Barrientos A. Asistencia mecánica circulatoria como puente al trasplante Cir Cardiov. 2016; 23(S1): 41-48.

  4. Gómez-Bueno M, Segovia-Cubero J, Alonso-Pulpón Rivera L. Mechanical cardiac assist devices and heart transplantation. Treatment indications and the current situation in Spain. Rev Esp Cardiol. 2006; Suppl (6) F: 82-94.

  5. Paredes-Cordero A, Suárez-Rivero A, Sánchez N, Martínez-Torres G. Dispositivos de asistencia circulatoria mecánica estado actuales. Rev Cubana Cardiol Cir Cardiovasc. 2010; 16: 452-465.

  6. Sayer G, Naka Y, Jorde U. Ventricular assist device therapy. Cardiovasc Ther.2009; 27 (2): 140-150.

  7. Alba A, Rao V, Ivanov J, Ross H, Delgado D. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplantat. 2009; 28 (8): 827-833.

  8. Vázquez López-Cepero A. Dispositivos de asistencia mecánica circulatoria (I y II). Curso intensivo del diploma Europeo de Anestesiología y Cuidados Intensivos. 7º ed. Disponible en: http://www.cideaci.es/

  9. Manito N, González CJ, Salazar MJ. ¿Qué nos aportan los dispositivos y técnicas quirúrgicas percutáneas en el tratamiento de la insuficiencia cardiaca avanzada? Cardiocore 2015; 50 (1): 8-11.

  10. Savarese G, Lund L. Global public health burden of heart failure. Card Fail Rev. 2017; 3 (1): 7-11.

  11. Thiagarajan RR, Barbaro RP, Rycus PT, Mcmullan DM, Conrad SA, Fortenberry JD et al. Extracorporeal life support organization registry international report 2016. ASAIO J. 2017; 63 (1): 60-67.

  12. Gosev I, Kiernan MS, Eckman P, Soleimani B, Kilic A, Uriel N et al. Long-term survival in patients receiving a continuous-flow left ventricular assist device. Ann Thorac Surg. 2018; 105 (3): 696-701.



EVIDENCE LEVEL

IV




2020     |     www.medigraphic.com